Meta-analysis of randomized phase II and phase III trials of gemcitabine with/without S-1 in Asian patients with advanced pancreatic cancer.
Geoffrey Yuyat Ku
No relevant relationships to disclose
Benjamin Haaland
No relevant relationships to disclose
Tatsuya Ioka
Research Funding - Chugai Pharma; Roche; Taiho Pharmaceutical; Yakult
Hiroyuki Isayama
No relevant relationships to disclose
Yousuke Nakai
No relevant relationships to disclose
Ann-Lii Cheng
No relevant relationships to disclose
Takuji Okusaka
No relevant relationships to disclose
Gilberto de Lima Lopes
Honoraria - Lilly; Taiho Pharmaceutical